Skip to main content
Erschienen in: Reactions Weekly 1/2013

01.08.2013 | Clinical study

Rivastigmine patch application-site reactions infrequent and mild

Erschienen in: Reactions Weekly | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Excerpt

Less than one-quarter of patients experience application-site reactions while receiving a rivastigmine patch, according to a retrospective analysis of two US, randomised, double-blind studies. …
Literatur
Zurück zum Zitat Alva G, et al. Infrequent Skin Reactions at the Application Site of the Rivastigmine Patch (4.6, 9.5 or 13.3 mg/24 h): Analysis of Two Clinical Studies Revealed Most Were Tolerable and Manageable Across All Doses. 2013 Alzheimer's Association International Conference : abstr. P3-299, 13 Jul 2013. Alva G, et al. Infrequent Skin Reactions at the Application Site of the Rivastigmine Patch (4.6, 9.5 or 13.3 mg/24 h): Analysis of Two Clinical Studies Revealed Most Were Tolerable and Manageable Across All Doses. 2013 Alzheimer's Association International Conference : abstr. P3-299, 13 Jul 2013.
Metadaten
Titel
Rivastigmine patch application-site reactions infrequent and mild
Publikationsdatum
01.08.2013
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2013
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-013-5446-y

Weitere Artikel der Ausgabe 1/2013

Reactions Weekly 1/2013 Zur Ausgabe

Case report

Xylometazoline

Case report

Gemcitabine

Case report

Rifampicin